References
Colombo M, Kuo G, Choo QL, et al: Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet 2:1006–1008, 1989
Bruix J, Barrera JM, Calvet X, et al: Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet 2:1004–1006, 1989
Marmo R, Romano M, de Sio I, Peduto A, Caporaso N, Persico M, Coltorti M: Decision-making model for a non-invasive diagnosis of compensated liver cirrhosis. Ital J Gastroenterol 25:1–8, 1993
Caporaso N, Romano M, Marmo R, de Sio I, Morisco F, Minerva A, Coltorti M: Hepatitis C virus infection is an additive risk factor for development of hepatocellular carcinoma in patients with cirrhosis. J Hepatol 12:367–371, 1991
Bressac B, Galvin KM, Liang TJ, Isselbacher KJ, Wands JR, Ozturk M: Abnormal structure and expression ofp53 gene in human hepatocellular carcinoma. Proc Natl Acad Sci USA 87:1973–1977, 1990
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Coltorti, M., Caporaso, N., Persico, M. et al. HCV infection and hepatocellular carcinoma in cirrhotics: What is the linkage?. Digest Dis Sci 39, 1596–1597 (1994). https://doi.org/10.1007/BF02088075
Issue Date:
DOI: https://doi.org/10.1007/BF02088075